Click here to close now.




















Welcome!

News Feed Item

Upcoming Earnings Schedule, Supply and Collaboration Agreements, Financial Results, and Stock Options - Research Report on Natus, Haemonetics, AngioDynamics, Horizon Pharma, and ImmunoGen

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, January 15, 2014 /PRNewswire/ --

Today, Analysts' Corner announced new research reports highlighting Natus Medical, Inc. (NASDAQ: BABY), Haemonetics Corporation (NYSE: HAE), AngioDynamics, Inc. (NASDAQ: ANGO), Horizon Pharma, Inc. (NASDAQ: HZNP), and ImmunoGen, Inc. (NASDAQ: IMGN). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Natus Medical, Inc. Research Report

On January 8, 2014, Natus Medical, Inc. (Natus) announced that it will release its Q4 2013 financial results on January 29, 2014, before the market opens. The Company stated that its management will host an investment-community conference call on the same day at 8:00 a.m. PT / 11:00 a.m. ET to discuss the results, as well as to answer questions. Natus added that the call can be accessed through its website, where a recording of the call will be available for 90 days after the call concludes. The Full Research Report on Natus Medical, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/03ac_BABY  

--

Haemonetics Corporation Research Report

On January 12, 2014, Haemonetics Corporation (Haemonetics) announced that it has entered into a multi-year agreement with HemeXcel Purchasing Alliance LLC (HemeXcel) to supply HemeXcel with certain whole blood collection components on an exclusive basis during 2014-2016. Brian Concannon, Haemonetics' President and CEO, commented, "We are very pleased with our selection by HemeXcel to meet their needs for whole blood collection products. We appreciate their confidence in our ability to deliver high quality products and services economically." Haemonetics added that the incremental business volume is not expected to have a material impact on its FY 2014 revenue or earnings. According to the Company, the incremental volume will represent approximately five net points of US whole blood disposables share gain in FY 2015 and beyond, considered together with a smaller recent U.S. tender that was not awarded to the Company. Haemonetics informed that a live webcast presentation will be held at 10:00 a.m. PT / 1:00 p.m. ET on January 15, 2014 to comment on this agreement. The Full Research Report on Haemonetics Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/7c61_HAE

--

AngioDynamics, Inc. Research Report

On January 9, 2014, AngioDynamics, Inc. (AngioDynamics) reported financial results for Q2 FY 2014 (period ended November 30, 2013). In Q2 FY 2014, the Company's net sales increased 1.8% YoY to $88.6 million, while net loss for the quarter was c.$0.1 million, or break-even on a per share basis, compared to net income of c.$2 million, or $0.06 per diluted share, in Q2 FY 2013. Joseph M. DeVivo, President and CEO of AngioDynamics, commented, "AngioDynamics' better than expected sales reflects improved performance in our three businesses - Peripheral Vascular, Vascular Access and Oncology/Surgery - compared to the prior quarter. Our new products, specifically AngioVac, BioFlo PICCs and ports, and the Acculis microwave system, represent disruptive emerging technologies that are contributing to our growth while improving patient outcomes and reducing costs to the healthcare system." Mark Frost, Executive Vice President and CFO, added, "We are anticipating revenue to range from $85 million to $88 million in the fiscal third quarter of 2014, a 4% to 8% increase at the top end compared with the year ago fiscal third quarter. Adjusted EPS, excluding amortization, is expected to be $0.15 to $0.18 per share." The Full Research Report on AngioDynamics, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/3fa9_ANGO

--

Horizon Pharma, Inc. Research Report

On January 9, 2014, Horizon Pharma, Inc. (Horizon Pharma) announced that the Compensation Committee of the Company's Board of Directors has approved the grant of inducement stock options to purchase an aggregate of 363,900 shares of common stock to 93 new employees, in accordance with the NASDAQ Listing Rule 5635(c)(4). The Company informed that each stock option has an exercise price per share of $8.59, vests over four years, has a ten year term, and is subject to the terms and conditions of the Company's 2011 Equity Incentive Plan and the stock option agreement. The Full Research Report on Horizon Pharma, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/05ea_HZNP

--

ImmunoGen, Inc. Research Report

On January 9, 2014, ImmunoGen, Inc. (ImmunoGen) announced a multi-year, strategic collaboration with CytomX Therapeutics (CytomX) to develop Probody-drug conjugate (PDC) therapies for the treatment of cancer. ImmunoGen informed that under the agreement, the Companies will collaborate to develop PDCs against a defined number of targets, bringing together CytomX's proprietary antibody masking technology and tumor-selective protease substrates with ImmunoGen's antibody-drug conjugate (ADC) cell-killing agents and engineered linkers. John Lambert, PhD, Executive Vice President and Chief Scientific Officer of ImmunoGen, commented, "We believe using our state-of-the-art ADC technology with CytomX's highly promising Probody Platform will enable us to develop therapies particularly well-suited for certain challenging cancers." The Full Research Report on ImmunoGen, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/11c8_IMGN

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
  5. For any urgent concerns or inquiries, please contact us at [email protected].
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


AnalystsCorner.com

SOURCE Analysts' Corner

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In their session at 17th Cloud Expo, Hal Schwartz, CEO of Secure Infrastructure & Services (SIAS), and Chuck Paolillo, CTO of Secure Infrastructure & Services (SIAS), provide a study of cloud adoption trends and the power and flexibility of IBM Power and Pureflex cloud solutions. In his role as CEO of Secure Infrastructure & Services (SIAS), Hal Schwartz provides leadership and direction for the company.
There are many considerations when moving applications from on-premise to cloud. It is critical to understand the benefits and also challenges of this migration. A successful migration will result in lower Total Cost of Ownership, yet offer the same or higher level of robustness. In his session at 15th Cloud Expo, Michael Meiner, an Engineering Director at Oracle, Corporation, analyzed a range of cloud offerings (IaaS, PaaS, SaaS) and discussed the benefits/challenges of migrating to each offe...
SYS-CON Events announced today that the "Second Containers & Microservices Expo" will take place November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. Containers and microservices have become topics of intense interest throughout the cloud developer and enterprise IT communities.
As organizations shift towards IT-as-a-service models, the need for managing and protecting data residing across physical, virtual, and now cloud environments grows with it. CommVault can ensure protection and E-Discovery of your data – whether in a private cloud, a Service Provider delivered public cloud, or a hybrid cloud environment – across the heterogeneous enterprise. In his session at 17th Cloud Expo, Randy De Meno, Chief Technologist - Windows Products and Microsoft Partnerships at Com...
The Software Defined Data Center (SDDC), which enables organizations to seamlessly run in a hybrid cloud model (public + private cloud), is here to stay. IDC estimates that the software-defined networking market will be valued at $3.7 billion by 2016. Security is a key component and benefit of the SDDC, and offers an opportunity to build security 'from the ground up' and weave it into the environment from day one. In his session at 16th Cloud Expo, Reuven Harrison, CTO and Co-Founder of Tufin,...
Scrum Alliance has announced the release of its 2015 State of Scrum Report. Almost 5,000 individuals and companies worldwide participated in this year's survey. Most organizations in the market today are still leading and managing under an Industrial Age model. Not only is the speed of change growing exponentially, Agile and Scrum frameworks are showing companies how to draw on the full talents and capabilities of those doing the work in order to continue innovating for success.
SYS-CON Events announced today that MobiDev, a software development company, will exhibit at the 17th International Cloud Expo®, which will take place November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software development company with representative offices in Atlanta (US), Sheffield (UK) and Würzburg (Germany); and development centers in Ukraine. Since 2009 it has grown from a small group of passionate engineers and business managers to a full-scale mobi...
Between the compelling mockups and specs produced by your analysts and designers, and the resulting application built by your developers, there is a gulf where projects fail, costs spiral out of control, and applications fall short of requirements. In his session at @DevOpsSummit, Charles Kendrick, CTO and Chief Architect at Isomorphic Software, presented a new approach where business and development users collaborate – each using tools appropriate to their goals and expertise – to build mocku...
Container technology is sending shock waves through the world of cloud computing. Heralded as the 'next big thing,' containers provide software owners a consistent way to package their software and dependencies while infrastructure operators benefit from a standard way to deploy and run them. Containers present new challenges for tracking usage due to their dynamic nature. They can also be deployed to bare metal, virtual machines and various cloud platforms. How do software owners track the usag...
SYS-CON Events announced today that VividCortex, the monitoring solution for the modern data system, will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. The database is the heart of most applications, but it’s also the part that’s hardest to scale, monitor, and optimize even as it’s growing 50% year over year. VividCortex is the first unified suite of database monitoring tools specifically desi...
Graylog, Inc., has added the capability to collect, centralize and analyze application container logs from within Docker. The Graylog logging driver for Docker addresses the challenges of extracting intelligence from within Docker containers, where most workloads are dynamic and log data is not persisted or stored. Using Graylog, DevOps and IT Ops teams can pinpoint the root cause of problems to deliver new applications faster and minimize downtime.
As Marc Andreessen says software is eating the world. Everything is rapidly moving toward being software-defined – from our phones and cars through our washing machines to the datacenter. However, there are larger challenges when implementing software defined on a larger scale - when building software defined infrastructure. In his session at 16th Cloud Expo, Boyan Ivanov, CEO of StorPool, provided some practical insights on what, how and why when implementing "software-defined" in the datacent...
Learn how you can use the CoSN SEND II Decision Tree for Education Technology to make sure that your K–12 technology initiatives create a more engaging learning experience that empowers students, teachers, and administrators alike.
Mobile, social, Big Data, and cloud have fundamentally changed the way we live. “Anytime, anywhere” access to data and information is no longer a luxury; it’s a requirement, in both our personal and professional lives. For IT organizations, this means pressure has never been greater to deliver meaningful services to the business and customers.
In a recent research, analyst firm IDC found that the average cost of a critical application failure is $500,000 to $1 million per hour and the average total cost of unplanned application downtime is $1.25 billion to $2.5 billion per year for Fortune 1000 companies. In addition to the findings on the cost of the downtime, the research also highlighted best practices for development, testing, application support, infrastructure, and operations teams.